Skip to content
2000
Volume 16, Issue 3
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Urolithiasis is a condition where kidney stones exit through the renal pelvis, causing chronic pain. Kidney stones are usually formed due to the deposition of calcium and oxalate crystals. It is known to be a prevalent health condition that affects a large portion of the global human population. Inopportunely, no medications that show effective prevention of urolithiasis are currently available. Extensive research has highlighted the significant role of commensal microbes in regulating host oxalate homeostasis and oxalate-associated pathological conditions. However, limited knowledge of the pathophysiology of urolithiasis poses difficulties in designing target-based therapeutics. Growing evidence suggests the role of gut microbiota and probiotics in helping reduce the disease burden. Understanding the intricate relationship between gut-associated microbiota and its host symbiosis reveals the therapeutic potential of specific bacteria to prevent and/or treat such metabolic diseases. , a bacterium, is considered crucial for degrading dietary oxalates through the oxalyl-CoA decarboxylase enzyme. The absence of this enzyme leads to hyperoxaluria and calcium oxalate urolithiasis, underscoring the impact of microbiota on kidney stone formation. Studies on the urinary microbiome, including those focusing on and , elucidate the metabolism of dietary oxalates, providing a novel approach to kidney stone management. This review aims to consolidate the present information on the urinary microbiome, aetiology, pathogenesis, and disease prevention.

© 2026 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155352643241205175402
2025-02-03
2026-02-19

  • From This Site

    /content/journals/npj/10.2174/0122103155352643241205175402
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/npj/16/3/NPJ-16-3-05.html?itemId=/content/journals/npj/10.2174/0122103155352643241205175402&mimeType=html&fmt=ahah

References

  1. SinghA. ChitraV. A probe on the activity of herbal medicines in nephrolithiasis.Research J. Pharm. and Tech.20191294539454410.5958/0974‑360X.2019.00781.9
     [Google Scholar]
  2. KalyaniK. SailajaB. An overview on analytical methods for bioactive markers used in urolithiasis.Asian J. Pharm. Sci.2022124321328
     [Google Scholar]
  3. Kabita BanikS. AkshithaO.V. PoojithaC.H. ThulasiV. Evaluation of antiurolithiatic activity of Moringa leaves by UV spectroscopic method.Asian J. Res. Pharm. Sci.2020103141144
     [Google Scholar]
  4. LieskeJ.C. TremaineW.J. De SimoneC. O’ConnorH.M. LiX. BergstralhE.J. GoldfarbD.S. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.Kidney Int.201078111178118510.1038/ki.2010.310 20736987
     [Google Scholar]
  5. TroxelS.A. SidhuH. KaulP. LowR.K. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.J. Endourol.200317317317610.1089/089277903321618743 12803990
     [Google Scholar]
  6. SpandanaK. ShivaniM. HimabindhuJ. RamanjaneyuluK. Evaluation of In Vitro antiurolithiatic activity of Vigna radiata.Research J. Pharm. and Tech.201811125455545710.5958/0974‑360X.2018.00994.0
     [Google Scholar]
  7. SienerR. BangenU. SidhuH. HönowR. von UnruhG. HesseA. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.Kidney Int.20138361144114910.1038/ki.2013.104 23536130
     [Google Scholar]
  8. GuptaS. ShamsherS.K. Kidney stones: Mechanism of formation, pathogenesis and possible treatments.J. Biomol. Biochem.20182115
     [Google Scholar]
  9. ZalavadiyaV. SantaniV.S. A review on urolithiasis and its treatment using plants.J. Pharmacogn. Phytochem.20135118
     [Google Scholar]
  10. EvanA.P. WorcesterE.M. CoeF.L. WilliamsJ.Jr LingemanJ.E. Mechanisms of human kidney stone formation.Urolithiasis201543S1Suppl. 1193210.1007/s00240‑014‑0701‑0 25108546
     [Google Scholar]
  11. RebecaD. Monk DavidA. Kidney Stones.In: Williams Textbook of Endocrinology.12th edElsevier20111296136710.1016/B978‑1‑4377‑0324‑5.00030‑4
     [Google Scholar]
  12. AggarwalP.K. NarulaS. KakkarM. TondonC. Nephrolithiasis: Molecular mechanism of renal stone formation and the critical role played by modulators.BioMed. Res. Int.20132013292953
     [Google Scholar]
  13. LieskeJ.C. Peña de la VegaL.S. SlezakJ.M. BergstralhE.J. LeibsonC.L. HoK.L. GettmanM.T. Renal stone epidemiology in Rochester, Minnesota: An update.Kidney Int.200669476076410.1038/sj.ki.5000150 16518332
     [Google Scholar]
  14. MayansL. Nephrolithiasis.Prim. Care201946220321210.1016/j.pop.2019.02.001 31030821
     [Google Scholar]
  15. ScalesC.D.Jr SmithA.C. HanleyJ.M. SaigalC.S. Prevalence of kidney stones in the United States.Eur. Urol.201262116016510.1016/j.eururo.2012.03.052 22498635
     [Google Scholar]
  16. CurhanG.C. WillettW.C. RimmE.B. StampferM.J. Family history and risk of kidney stones.J. Am. Soc. Nephrol.19978101568157310.1681/ASN.V8101568 9335385
     [Google Scholar]
  17. StamatelouK.K. FrancisM.E. JonesC.A. NybergL.M.Jr CurhanG.C. Time trends in reported prevalence of kidney stones in the United States.Kidney Int.20036351817182310.1046/j.1523‑1755.2003.00917.x 12675858
     [Google Scholar]
  18. RomeroV. AkpinarH. AssimosD.G. Kidney stones: A global picture of prevalence, incidence, and associated risk factors.Rev. Urol.2010122-3e86e96 20811557
     [Google Scholar]
  19. FerraroP.M. BargagliM. TrinchieriA. GambaroG. Risk of kidney stones: Influence of dietary factors, dietary patterns, and vegetarian–vegan diets.Nutrients202012377910.3390/nu12030779 32183500
     [Google Scholar]
  20. TasianG. MillerA. LangeD. Antibiotics and kidney stones: Perturbation of the gut-kidney axis.Am. J. Kidney Dis.201974672472610.1053/j.ajkd.2019.07.021 31635850
     [Google Scholar]
  21. TasianG.E. JemielitaT. GoldfarbD.S. CopelovitchL. GerberJ.S. WuQ. DenburgM.R. Oral antibiotic exposure and kidney stone disease.J. Am. Soc. Nephrol.20182961731174010.1681/ASN.2017111213 29748329
     [Google Scholar]
  22. SternJ.M. MoazamiS. QiuY. KurlandI. ChenZ. AgalliuI. BurkR. DaviesK.P. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.Urolithiasis201644539940710.1007/s00240‑016‑0882‑9 27115405
     [Google Scholar]
  23. TaylorE.N. CurhanG.C. Oxalate intake and the risk for nephrolithiasis.J. Am. Soc. Nephrol.20071872198220410.1681/ASN.2007020219 17538185
     [Google Scholar]
  24. ZabłockaA. JanuszM. The two faces of reactive oxygen species.Postepy Hig. Med. Dosw.200862118124 18388851
     [Google Scholar]
  25. HolmesR.P. GoodmanH.O. AssimosD.G. Contribution of dietary oxalate to urinary oxalate excretion.Kidney Int.200159127027610.1046/j.1523‑1755.2001.00488.x 11135080
     [Google Scholar]
  26. RatkalkarV.N. KleinmanJ.G. Mechanisms of stone formation.Clin. Rev. Bone Miner. Metab.201193-418719710.1007/s12018‑011‑9104‑8 22229020
     [Google Scholar]
  27. SharmaS. SharmaN. Chandra GuptaP. VermaR. YadavV. An update on kidney stones: Types, mechanism and treatment approaches.Res. J. Pharmacogn. Phytochem.2023151536210.52711/0975‑4385.2023.00009
     [Google Scholar]
  28. SathishR. NatarajanK. NikhadM.M. Effect of Hygrophila spinosa T Anders on ethylene glycol induced urolithiasis in rats.Asian J. Pharm. Clin. Res.2010346163
     [Google Scholar]
  29. TicinesiA. MilaniC. GuerraA. AllegriF. LauretaniF. NouvenneA. MancabelliL. LugliG.A. TurroniF. DurantiS. MangifestaM. ViappianiA. FerrarioC. DodiR. Dall’AstaM. Del RioD. VenturaM. MeschiT. Understanding the gut–kidney axis in nephrolithiasis: An analysis of the gut microbiota composition and functionality of stone formers.Gut201867122097210610.1136/gutjnl‑2017‑315734 29705728
     [Google Scholar]
  30. EdvardssonV.O. GoldfarbD.S. LieskeJ.C. Beara-LasicL. AnglaniF. MillinerD.S. PalssonR. Hereditary causes of kidney stones and chronic kidney disease.Pediatr. Nephrol.201328101923194210.1007/s00467‑012‑2329‑z 23334384
     [Google Scholar]
  31. HowlesS.A. ThakkerR.V. Genetics of kidney stone disease.Nat. Rev. Urol.202017740742110.1038/s41585‑020‑0332‑x 32533118
     [Google Scholar]
  32. AbrattV.R. ReidS.J. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.Adv. Appl. Microbiol.201072638710.1016/S0065‑2164(10)72003‑7 20602988
     [Google Scholar]
  33. JoshiS. GoldfarbD.S. The use of antibiotics and risk of kidney stones.Curr. Opin. Nephrol. Hypertens.201928431131510.1097/MNH.0000000000000510 31145705
     [Google Scholar]
  34. MehtaM. GoldfarbD.S. NazzalL. The role of the microbiome in kidney stone formation.Int. J. Surg.201636Pt D60761210.1016/j.ijsu.2016.11.024 27847292
     [Google Scholar]
  35. HatchM. CorneliusJ. AllisonM. SidhuH. PeckA. FreelR.W. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.Kidney Int.200669469169810.1038/sj.ki.5000162 16518326
     [Google Scholar]
  36. KaufmanD.W. KellyJ.P. CurhanG.C. AndersonT.E. DretlerS.P. PremingerG.M. CaveD.R. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.J. Am. Soc. Nephrol.20081961197120310.1681/ASN.2007101058 18322162
     [Google Scholar]
  37. TarasewiczA. LaudańskaE. NaumnikB. Oxalobacter formigenes – wykorzystanie mikrobiomu jelita grubego w profilaktyce kamicy nerkowej Oxalobacter formigenes - use of the colon microbiome in the prevention of kidney stones.Pol. Merkur Lekarski.2022502955457
     [Google Scholar]
  38. JiangJ. KnightJ. EasterL.H. NeibergR. HolmesR.P. AssimosD.G. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.J. Urol.2011186113513910.1016/j.juro.2011.03.006 21575973
     [Google Scholar]
  39. TavasoliS. AlebouyehM. NajiM. Shakiba majd, G.; Shabani Nashtaei, M.; Broumandnia, N.; Basiri, A. Association of intestinal oxalate‐degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: A case–control study.BJU Int.2020125113314310.1111/bju.14840 31145528
     [Google Scholar]
  40. BatislamE. YilmazE. YuvancE. KisaO. KisaU. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.Urol. Res.201240545546010.1007/s00240‑011‑0449‑8 22215293
     [Google Scholar]
  41. RavikumarY. BegumR.F. VelmuruganR. Oxalobacter formigenes reduce the risk of kidney stones in patients exposed to oral antibiotics: A case–control study.Int. Urol. Nephrol.2021531132010.1007/s11255‑020‑02627‑3 32880090
     [Google Scholar]
  42. VerhulstA. DehmelB. LindnerE. AkermanM.E. D’HaeseP.C. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.Urolithiasis202250211913010.1007/s00240‑022‑01310‑9 35122487
     [Google Scholar]
  43. SidhuH. AllisonM.J. ChowJ.O.M. ClarkA. PeckA.B. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.J. Urol.200116641487149110.1016/S0022‑5347(05)65817‑X 11547118
     [Google Scholar]
  44. KlimesovaK. WhittamoreJ.M. HatchM. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.Urolithiasis201543210711710.1007/s00240‑014‑0728‑2 25269440
     [Google Scholar]
  45. AlK.F. DaisleyB.A. ChanyiR.M. BjazevicJ. RazviH. ReidG. BurtonJ.P. Oxalate-degrading Bacillus subtilis mitigates urolithiasis in a Drosophila melanogaster Model.MSphere202055e0049810.1128/mSphere.00498‑20
     [Google Scholar]
  46. AnbazhaganK. SasikumarP. GomathiS. PriyaH.P. SelvamG.S. In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase.J. Appl. Microbiol.2013115388088710.1111/jam.12269 23734819
     [Google Scholar]
  47. AntonelliJ.A. MaaloufN.M. PearleM.S. LotanY. Use of the national health and nutrition examination survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.Eur. Urol.201466472472910.1016/j.eururo.2014.06.036 25015037
     [Google Scholar]
  48. ArvansD. JungY.C. AntonopoulosD. KovalJ. GranjaI. BashirM. KarrarE. Roy-ChowdhuryJ. MuschM. AsplinJ. ChangE. HassanH. Oxalobacter formigenes–derived bioactive factors stimulate oxalate transport by intestinal epithelial cells.J. Am. Soc. Nephrol.201728387688710.1681/ASN.2016020132 27738124
     [Google Scholar]
/content/journals/npj/10.2174/0122103155352643241205175402
Loading
Therapeutic Applications of Oxalate-degrading Bacteria in Kidney Stone Prevention
Natural Products Journal, The 16, e22103155352643 (2026); https://doi.org/10.2174/0122103155352643241205175402
/content/journals/npj/10.2174/0122103155352643241205175402
/content/journals/npj/10.2174/0122103155352643241205175402
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): calcium oxalate; hyperoxaluria; microbiome; Oxalobacter formigenes; pathophysiology; Urolithiasis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test